By Mill Chart
Last update: Jan 30, 2024
For growth-minded investors, high revenue and EPS growth are key criteria. Today, we'll examine whether GLOBUS MEDICAL INC - A (NYSE:GMED) fits the bill for growth investing, particularly as it forms a base and hints at a potential breakout. Remember, due diligence is essential, but GLOBUS MEDICAL INC - A has caught our attention on our screen for growth with base formation. It may warrant additional investigation.
ChartMill assigns a Growth Rating to every stock. This score ranges from 0 to 10 and evaluates the different growth aspects like EPS and Revenue, both in the past as in the future. NYSE:GMED scores a 8 out of 10:
ChartMill employs its own Health Rating for stock assessment. This rating, ranging from 0 to 10, is calculated by examining various liquidity and solvency ratios. In the case of NYSE:GMED, the assigned 7 reflects its health status:
ChartMill employs its own Profitability Rating system for stock evaluation. This score, ranging from 0 to 10, is derived from an analysis of diverse profitability metrics and margins. In the case of NYSE:GMED, the assigned 8 is noteworthy for profitability:
Alongside the Technical Rating, ChartMill assigns a Setup Rating to evaluate the consolidation level of a stock. This rating, ranging from 0 to 10, is updated daily and considers various short-term technical indicators. The current setup rating for NYSE:GMED is 8:
Besides having an excellent technical rating, GMED also presents a decent setup pattern. Prices have been consolidating lately and the volatility has been reduced. A pullback is taking place, which may present a nice opportunity for an entry. There is a resistance zone just above the current price starting at 56.25. Right above this resistance zone may be a good entry point. There is a support zone below the current price at 54.38, a Stop Loss order could be placed below this zone.
More Strong Growth stocks can be found in our Strong Growth screener.
For an up to date full fundamental analysis you can check the fundamental report of GMED
For an up to date full technical analysis you can check the technical report of GMED
This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.
GLOBUS MEDICAL INC - A
NYSE:GMED (4/26/2024, 7:04:00 PM)
After market: 50.55 0 (0%)50.55
+0.18 (+0.36%)
AUDUBON, Pa., April 16, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its...
GLOBUS MEDICAL INC - A (NYSE:GMED) is showing good growth, while it is not too expensive.
With automated machines set to integrate into everyday functionalities, these are the robotics stocks that could make you rich.
Discover seven robotic surgery stocks primed for growth as the industry evolves. Unveil opportunities in a market set to double by 2033.
GMED earnings call for the period ending December 31, 2023.
AUDUBON, Pa., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the fourth quarter and year ended December 31, 2023.